《大行報告》高盛下調聯易融科技-W(09959.HK)目標價至21.6元 評級「買入」
高盛發表研究報告指,經歷次季困難經營環境後,聯易融科技(09959.HK)的資產線上獲取審核平台(AMS)及資產支持證券(ABS)交易量有復甦跡象,預計第三季整體交易量可按年增長43%至758億元人民幣,收入回升40%至3.92億元人民幣。
該行指出,由於SHIBOR自7月下旬起有所回落,令宏觀環境更有利;內地發展商需求壓抑,推動明年ABS發行額度增長,以及直接出售予金融機構的證券化資產有所增加等,將帶動下半年AMS及ABS成交量回升。
高盛預期下半年聯易融的交易量及收入將按年增長60%及55%,經調整淨利潤按年升39%,但將2022至2025年收入及調整淨利潤預測平均下調7%及6%,目標價由25元降至21.6元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.